Skip to main content
Premium Trial:

Request an Annual Quote

Greg Weaver, Michael French, Janet Woodcock, Alan Aderem, Charles Cantor, Michael Hanley

Premium
Two of Sirna Therapeutics’ senior executives have left the company following its recent acquisition by Merck, RNAi News has learned.
 
According to Bharat Chowrira, Sirna’s vice president of legal affairs and general counsel, the company’s CFO Greg Weaver and senior vice president of corporate development Michael French have left to pursue other opportunities.
Additional details were not available.
 
Earlier this month, Nektar Pharmaceuticals said that it had tapped Sirna’s former President and CEO Howard Robin to be its new president and CEO.
 

 
The US Food and Drug Administration has promoted deputy commissioner Janet Woodcock to chief medical officer, a newly created spot. She will retain her duties as deputy commissioner, the FDA said.
 
In these positions, Woodcock will be responsible for scientific and planning-related operations, including organizing, directing, staffing, coordinating, and planning.
 

 
Cyntellect has appointed three new members to its scientific advisory board.
 
The new members include Alan Aderem, an immunologist and cell biologist who worked at the University of Washington, and former head of the signal transduction laboratory at The Rockefeller University; Charles Cantor, chief scientific officer at Sequenom and former chair and professor of biomedical engineering at Boston University; and Michael Hanley, vice president of discovery research at Amylin Pharmaceuticals and former senior faculty at Imperial College in Cambridge, UK.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.